While NSE has not yet issued a formal announcement, SEBI’s clearance signals that the exchange can now begin formal preparations for its IPO, including finalising the offer structure and engaging with ...

2023 was a year of massive technological advancement. The way we work has completely shifted thanks to groundbreaking new inventions like generative AI – a tool so popular that we’re expected to see ...

SYDNEY (Reuters) -Australia's securities regulator said on Tuesday it would trial changes to speed up initial public offerings that are at a decade low by implementing recommendations from earlier ...

Having helped multiple companies navigate the IPO process, I’ve seen the same mistakes repeated over and over. The most common? Teams underestimate how much work happens in the year before going ...

At parent Imagine Marketing has deferred its IPO again despite SEBI clearance, amid weak market conditions, governance ...

Australia’s IPO market is showing early recovery signs with 2026 tipped to bring stronger listings activity. Initial public ...

Explains how companies qualify for a Main Board IPO, choose the right regulatory route, and comply with SEBI norms. Highlights key takeaways on pricing, subscription rules, and post-listing ...

Upon listing, Chatterbox Technologies Limited will become the first exclusive influencer marketing business in India to be listed on a public equity exchange. QYOU Media will remain the majority ...

Mobikwik is working with DAM Capital Advisors Ltd and SBI Capital Markets Ltd for the IPO The fintech unicorn is looking to raise $84 Mn (about INR 700 Cr) from the IPO and list next year The fintech ...

It’s been over a month since Facebook’s troubled initial public offering, and the fallout continues to reverberate from Wall Street to Capitol Hill. Angry shareholders have filed over 40 lawsuits ...

Telomir Pharmaceuticals, Inc. has filed for a mini-IPO to raise $13.8 million in funding. The company is a pre-clinical stage biopharma developing treatments for inflammatory diseases. Telomir is ...